313220-68-7 Usage
Explanation
The compound consists of 8 carbon atoms, 10 hydrogen atoms, 2 nitrogen atoms, and 3 oxygen atoms.
2. Heterocyclic compound
Explanation
The compound contains a ring structure with both carbon and nitrogen atoms, making it a heterocyclic compound.
3. Methyl ester derivative
Explanation
The compound is derived from 1H-pyrazole-3-carboxylic acid by attaching a methyl ester group to the carboxylic acid functional group.
4. Potential pharmaceutical applications
Explanation
Due to its unique structure and properties, this chemical may have potential uses in the pharmaceutical industry, such as in the development of new drugs or therapies.
5. Safety precautions
Explanation
As with any chemical substance, it is important to handle 1H-Pyrazole-3-carboxylic acid, 1-(hydroxymethyl)-5-methyl-, methyl ester (9CI) with care and in accordance with proper safety protocols and regulations to minimize risks associated with exposure or accidental ingestion.
6. Need for further research
Explanation
To fully understand the potential uses and effects of this chemical, additional research and study may be necessary to explore its properties, applications, and safety profile.
Check Digit Verification of cas no
The CAS Registry Mumber 313220-68-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,2,2 and 0 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 313220-68:
(8*3)+(7*1)+(6*3)+(5*2)+(4*2)+(3*0)+(2*6)+(1*8)=87
87 % 10 = 7
So 313220-68-7 is a valid CAS Registry Number.
313220-68-7Relevant academic research and scientific papers
Malek, Fouad,Draoui, Nihed,Feron, Olivier,Radi, Smaail
, p. 681 - 687 (2014)
Eight tridentate bipyrazole derivatives with different side arms have been prepared in one step and with good yields. The products were screened for their cytotoxic activity against three tumor cell lines - human breast cancer cell line MDA-MB231, human prostate cancer cell line PC3, and human colorectal cell line LoVo, by use of colorimetric MTT assay. Structure-activity relationships reflected the effect of substituted drugs. Among this series, two compounds had remarkable in-vitro antiproliferative activity against the LoVo cell line with IC50 values ranging from 2.6 to 2.7 μg ml-1. All the compounds had suitable drug-like characteristics according to Lipinski's rule.
